Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sacks

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The Journal of Pediatrics|November 1, 1973
Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancyJ Katz, S Krawitz, P V Sacks, et al.
JAMA|January 23, 2014
Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012Leonard V Sacks, Hala H Shamsuddin, Yuliya I Yasinskaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Adjunctive salvage therapy with inhaled aminoglycosides for patients with persistent smear-positive pulmonary tuberculosisL V Sacks, S Pendle, D Orlovic, et al.
The Journal of Infectious Diseases|September 1, 1991
A streptococcal erythrogenic toxin preparation augments natural killer activity of peripheral blood mononuclear cellsL V Sacks, F G Petermann, C K Lapham, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
HIV-1 infection abolishes CD4 biosynthesis but not CD4 mRNAM A Yuille, M Hugunin, P John, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The Journal of Pediatrics|November 1, 1973
Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancyJ Katz, S Krawitz, P V Sacks, et al.
JAMA|January 23, 2014
Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012Leonard V Sacks, Hala H Shamsuddin, Yuliya I Yasinskaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Adjunctive salvage therapy with inhaled aminoglycosides for patients with persistent smear-positive pulmonary tuberculosisL V Sacks, S Pendle, D Orlovic, et al.
The Journal of Infectious Diseases|September 1, 1991
A streptococcal erythrogenic toxin preparation augments natural killer activity of peripheral blood mononuclear cellsL V Sacks, F G Petermann, C K Lapham, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
HIV-1 infection abolishes CD4 biosynthesis but not CD4 mRNAM A Yuille, M Hugunin, P John, et al.
Pageof 4